Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq
Journal of Proteome Research · 06.11.2026 · 25 (11) · 5873-5883
DOI: 10.1021/acs.jproteome.6c00323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 24.09.2026. Verfasst von Munki Choo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio43210, United States. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Biofilms, Tobramycin, Anti-Bacterial Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Foundation for the National Institutes of Health, National Research Foundation of Korea.
Abstract (Originalsprache)
Biofilms are estimated to account for a large proportion of persistent microbial infections and are associated with substantial mortality in hospitals. Pseudomonas aeruginosa biofilms exhibit higher resistance to antibiotics compared to their planktonic growth form, making them difficult to eradicate and contributing to the mounting global challenge posed by infectious diseases. To gain deeper insights into the metabolic response of biofilms to antibiotic pressure, we conducted a quantitative, untargeted metabolomics analysis using heteronuclear 2D NMR spectroscopy. Biofilms were grown in the presence of sub-inhibitory concentrations of tobramycin, and metabolic alterations were identified and quantified using the COLMARq analysis platform. Our analysis revealed significant metabolic shifts even at low doses of tobramycin with key metabolites such as UDP-glucose increasing and putrescine decreasing. Pathway enrichment analysis highlighted alterations in amino acid biosynthesis, energy metabolism, and stress response pathways. Notably, the accumulation of glutathione disulfide indicates enhanced oxidative stress, while the depletion of β-alanine, succinate, and GABA suggested metabolic shifts linked to biofilm adaptation. These findings provide new insights into the metabolic reprogramming of biofilms under antibiotic treatment and offer perspectives into biofilm behavior in the case of Pseudomonas aeruginosa when exposed to antibiotics from an early stage of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio43210, United States.
- Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio43210, United States.
- Department of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, Ohio43210, United States.
ORCID-Profile: Munki Choo, Da-Wei Li, Rafael Brüschweiler
Förderung
- NIGMS NIH HHS
- Foundation for the National Institutes of Health
- National Research Foundation of Korea
Zitieren
APA
Choo, M., Li, D. W., Lee, K., Sindeldecker, D., Bruschweiler-Li, L., & Brüschweiler, R. (2026). Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq. Journal of Proteome Research, 25(11), 5873-5883. https://doi.org/10.1021/acs.jproteome.6c00323
Vancouver
Choo M, Li DW, Lee K, Sindeldecker D, Bruschweiler-Li L, Brüschweiler R. Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq. Journal of Proteome Research. 2026;25(11):5873-5883. doi:10.1021/acs.jproteome.6c00323
BibTeX
@article{Choo2026,
author = {Choo, Munki and Li, Da-Wei and Lee, Kyungsuh and Sindeldecker, Devin and Bruschweiler-Li, Lei and Brüschweiler, Rafael},
title = {Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {5873--5883},
doi = {10.1021/acs.jproteome.6c00323}
}
EUVIMED